These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28392848)

  • 41. Perspectives of Policy Makers and Service Users Concerning the Implementation of eHealth in Sweden: Interview Study.
    Neher M; Nygårdh A; Broström A; Lundgren J; Johansson P
    J Med Internet Res; 2022 Jan; 24(1):e28870. PubMed ID: 35089139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Talking about possible IVF/ICSI failure and need for multiple cycles in treatment planning: qualitative investigation of multi-cycle planning and its acceptability to patients and staff.
    Harrison C; Boivin J; Gameiro S
    Hum Reprod; 2022 Mar; 37(3):488-498. PubMed ID: 35040994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Scientists' Views on the Ethics, Promises and Practices of Synthetic Biology: A Qualitative Study of Australian Scientific Practice.
    Dalziell J; Rogers W
    Sci Eng Ethics; 2023 Dec; 29(6):41. PubMed ID: 38082028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Options for a rational dialogue on the acceptance of biotechnology.
    von Grebmer K; Omamo SW
    Biotechnol J; 2007 Sep; 2(9):1121-8. PubMed ID: 17703485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Opinions of key stakeholders on alternative interventions for malaria control and elimination in Tanzania.
    Finda MF; Christofides N; Lezaun J; Tarimo B; Chaki P; Kelly AH; Kapologwe N; Kazyoba P; Emidi B; Okumu FO
    Malar J; 2020 Apr; 19(1):164. PubMed ID: 32321534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Media representations of synthetic biology in China.
    Wang M; Du L
    Trends Biotechnol; 2023 Dec; 41(12):1459-1462. PubMed ID: 37393134
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Societal Risk Evaluation Scheme (SRES): Scenario-Based Multi-Criteria Evaluation of Synthetic Biology Applications.
    Cummings CL; Kuzma J
    PLoS One; 2017; 12(1):e0168564. PubMed ID: 28052080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. (Re-)Designing Nature? An Overview and Outlook on the Ethical and Societal Challenges in Synthetic Biology.
    Braun M; Fernau S; Dabrock P
    Adv Biosyst; 2019 Jun; 3(6):e1800326. PubMed ID: 32648715
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chemical Exposure: European Citizens' Perspectives, Trust, and Concerns on Human Biomonitoring Initiatives, Information Needs, and Scientific Results.
    Uhl M; Santos RR; Costa J; Santos O; Virgolino A; Evans DS; Murray C; Mulcahy M; Ubong D; Sepai O; Lobo Vicente J; Leitner M; Benda-Kahri S; Zanini-Freitag D
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33562859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New trends in science communication fostering evidence-informed policymaking.
    Szüdi G; Bartar P; Weiss G; Pellegrini G; Tulin M; Oomen T
    Open Res Eur; 2022; 2():78. PubMed ID: 37920848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Societal impact of synthetic biology: responsible research and innovation (RRI).
    Gregorowius D; Deplazes-Zemp A
    Essays Biochem; 2016 Nov; 60(4):371-379. PubMed ID: 27903824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visions and versions of governing biomedicine: narratives on power structures, decision-making and public participation in the field of biomedical technology in the Austrian context.
    Felt U; Fochler M; Mager A; Winkler P
    Soc Stud Sci; 2008 Apr; 38(2):233-57. PubMed ID: 18831132
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Different ways of problematising biotechnology--and what it means for technology governance.
    Bogner A; Torgersen H
    Public Underst Sci; 2015 Jul; 24(5):516-32. PubMed ID: 24966166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [From bioethics to the new technology ethics].
    Pompidou A
    Bull Mem Acad R Med Belg; 2000; 155(10-12):404-14. PubMed ID: 11475899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is 'health equity' bad for our health? A qualitative empirical ethics study of public health policy-makers' perspectives.
    Smith MJ; Thompson A; Upshur REG
    Can J Public Health; 2018 Dec; 109(5-6):633-642. PubMed ID: 30465285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparing for the introduction of hospital autonomy in Laos: an assessment of current situation and suggestions for policy-making.
    Geng J; Yu H; Chen Y
    Int J Health Plann Manage; 2016 Apr; 31(2):148-66. PubMed ID: 25677738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthetic Biology between Self-Regulation and Public Discourse: Ethical Issues and the Many Roles of the Ethicist.
    Arnason G
    Camb Q Healthc Ethics; 2017 Apr; 26(2):246-256. PubMed ID: 28361722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.